{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:14:13Z","timestamp":1792815253306,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.xphs.2025.103764","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T21:03:47Z","timestamp":1742418227000},"page":"103764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Procedural modifications proposed for the screening of substances extracted from pharmaceutical packaging systems and medical devices with the goal of improving inter-laboratory consistency of the data generated"],"prefix":"10.1016","volume":"114","author":[{"given":"Steven A.","family":"Zdravkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kikandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8753-8179","authenticated-orcid":false,"given":"Bhargava","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Creasey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Flick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kate","family":"Bielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103764_bib0001","series-title":"Container Closure Systems For Packaging Human Drugs and Biologics: Chemistry, Manufacturing, and Controls Documentation. U.S. Department of Health and Human Services: Food and Drug Administration; Center for Drug Evaluation and Research (CDER)","article-title":"Guidance for industry","author":"Food","year":"1999"},{"key":"10.1016\/j.xphs.2025.103764_bib0002","unstructured":"Guideline on Plastic Immediate Packaging Materials. European Medicines Agency Inspections; Committee for Medicinal Products for Human Use (CHMP), Committee for Medicinal Products for Veterinary Use (CVMP). CPMP\/QWP\/4359\/03. EMEA\/CVMP\/205\/04. London; 19 May 2005."},{"key":"10.1016\/j.xphs.2025.103764_bib0003","unstructured":"United States Pharmacopeia. Plastic materials of construction (661.1). In: USP-NF. 2025. https:\/\/online.uspnf.com\/uspnf\/document\/1GUID-560BA7C5-176D-4976-8AB2-A051582B39C712en-US."},{"key":"10.1016\/j.xphs.2025.103764_bib0004","unstructured":"United States Pharmacopeia. Plastic packaging systems for pharmaceutical use (661.2). In: USP-NF. 2025. https:\/\/online.uspnf.com\/uspnf\/document\/2GUID-BDDD4901-FC17-4F66-B9AC-03C279087E5850101en-US."},{"key":"10.1016\/j.xphs.2025.103764_bib0005","unstructured":"United States Pharmacopeia. Evaluation of plastic packaging systems for pharmaceutical use and their materials of construction (1661). In: USP-NF. 2020. https:\/\/online.uspnf.com\/uspnf\/document\/1GUID-1F18D8EA-7810-4F2B-A703-9CD977E0B2E86en-US."},{"key":"10.1016\/j.xphs.2025.103764_bib0006","unstructured":"United States Pharmacopeia. Assessment of extractables associated with pharmaceutical packaging\/delivery systems (1663). In: USP-NF. 2018. https:\/\/online.uspnf.com\/uspnf\/document\/1GUID-5B829ECA-165E-46C5-A244-3FF958BBC1903en-US."},{"key":"10.1016\/j.xphs.2025.103764_bib0007","unstructured":"United States Pharmacopeia. Assessment of leachables associated with pharmaceutical packaging\/delivery systems (1664). In: USP-NF. 2018. litlps:\/\/online.uspnf.com\/uspnf\/document\/1GUID-080B9CD2-A445-44A2-A529-2CC7F86BCC643en-US."},{"key":"10.1016\/j.xphs.2025.103764_bib0008","series-title":"Leachables and Extractables Working Group. Safety thresholds and Best Practices For Extractables and Leachables in Orally Inhaled and Nasal Drug Products","year":"2006"},{"key":"10.1016\/j.xphs.2025.103764_bib0009","series-title":"Safety Thresholds and Best Demonstrated Practices For Extractables and Leachables in Parenteral Drug Products (intravenous, subcutaneous, and Intramuscular)","year":"2021"},{"key":"10.1016\/j.xphs.2025.103764_bib0010","series-title":"Biological Evaluation of Medical Devices \u2013 Part 18: Chemical Characterization of Medical Device Materials within a Risk Management Process","year":"2022"},{"key":"10.1016\/j.xphs.2025.103764_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105164","article-title":"Report on investigation of ISO10993\u201312 extraction conditions","volume":"131","author":"Heise","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2025.103764_bib0012","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1208\/s12249-014-0249-x","article-title":"Controlled extraction studies applied to polyvinyl chloride and polyethylene materials: conclusions from the ELSIE Controlled extraction Pilot Study","volume":"16","author":"Teasdale","year":"2014","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.xphs.2025.103764_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116496","article-title":"Inter-laboratory study for extraction testing of medical devices","volume":"252","author":"Saylor","year":"2025","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.xphs.2025.103764_bib0014","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12249-014-0188-6","article-title":"Evaluation of extractables in processed and unprocessed polymer materials used for pharmaceutical applications","volume":"16","author":"Stults","year":"2015","journal-title":"AAPS Pharm Sci Tech"},{"issue":"1","key":"10.1016\/j.xphs.2025.103764_bib0015","doi-asserted-by":"crossref","DOI":"10.17145\/rss.22.004","article-title":"Reporting analytical data for regulatory submissions: a CRO perspective on implementing the BP4NTA study Reporting tool in the healthcare industry","volume":"4","author":"Dunn","year":"2022","journal-title":"Rev. Sep. Sci."},{"issue":"4","key":"10.1016\/j.xphs.2025.103764_bib0016","first-page":"329","article-title":"Standardization of chromatographic screening methods for organic extractables and leachables by managing outcomes","volume":"77","author":"Jenke","year":"2023","journal-title":"J Pharm Sci Tech"},{"issue":"5","key":"10.1016\/j.xphs.2025.103764_bib0017","article-title":"Understanding alignment in the execution of extractable screening studies between laboratories: results of the ELSIE lab Practices Sub-team industry surveys","volume":"78","author":"Zdravkovic","year":"2024","journal-title":"PDA J. Pharm. Sci. Tech."},{"key":"10.1016\/j.xphs.2025.103764_bib0018","first-page":"241","article-title":"Identification and quantification of medical device extractables and leachables via non-target analysis (NTA); analytical uncertainty","author":"Jenke","year":"2024","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"10.1016\/j.xphs.2025.103764_bib0020","first-page":"348","article-title":"Correcting the analytical evaluation threshold (AET) and reported extractable's concentrations for analytical response factor uncertainty associated with chromatographic screening for extractables\/leachables","volume":"74","author":"Jenke","year":"2020","journal-title":"J Pharm Sci Tech"},{"issue":"3","key":"10.1016\/j.xphs.2025.103764_bib0023","first-page":"236","article-title":"Is retention time and\/or structure matching a solution to the challenge of providing quantitative data when screening for extractables and leachabales by GC\/MS?","volume":"76","author":"Jenke","year":"2022","journal-title":"J Pharm Sci Tech"},{"key":"10.1016\/j.xphs.2025.103764_bib0021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpba.2017.12.054","article-title":"Establishment of a reference standard database for use in the qualitative and semi-quantitative analysis of pharmaceutical contact materials within an extractables survey by GC\/MS","volume":"151","author":"Zdravkovic","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2025.103764_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116286","article-title":"Analytical challenges and recent advances in the identification and quantitation of extractables and leachables in pharmaceutical and medical products","volume":"141","author":"Singh","year":"2021","journal-title":"Trends in Anal Chem"},{"issue":"2","key":"10.1016\/j.xphs.2025.103764_bib0019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5731\/pdajpst.2019.010538","article-title":"Identification and quantification classifications for extractables and leachables","volume":"74","author":"Jenke","year":"2020","journal-title":"PDA J Pharm Sci Tech"},{"key":"10.1016\/j.xphs.2025.103764_bib0025","article-title":"Proposals for the development, composition, and routing use of system suitability standard mixtures in support of chromatographic screening for organic extractables and leachables","author":"Jenke","year":"2023","journal-title":"Unites States Pharmacopeia"},{"key":"10.1016\/j.xphs.2025.103764_bib0024","article-title":"ICH Q2(R2) guideline on validation of analytical procedures. International counsil for harmonization of technical requirements for pharmaceuticals for Human use","year":"2022","journal-title":"Effective"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:33:58Z","timestamp":1745501638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925002229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022354925002229"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103764","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procedural modifications proposed for the screening of substances extracted from pharmaceutical packaging systems and medical devices with the goal of improving inter-laboratory consistency of the data generated","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103764"}}